Total Payments
$4,159
2022 Payments
$3,417
Companies
6
Transactions
17
Medicare Patients
5,100
Medicare Billing
$545,516
Payment Breakdown by Category
Consulting$3,281 (78.9%)
Education$459.12 (11.0%)
Food & Beverage$418.39 (10.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,281 | 2 | 78.9% |
| Education | $459.12 | 7 | 11.0% |
| Food and Beverage | $418.39 | 8 | 10.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,281 | 2 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $377.41 | 6 | $0 (2018) |
| Incyte Corporation | $355.98 | 6 | $0 (2022) |
| PFIZER INC. | $109.40 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $22.21 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $12.51 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $3,417 | 5 | Novartis Pharmaceuticals Corporation ($3,281) |
| 2020 | $12.51 | 1 | Janssen Biotech, Inc. ($12.51) |
| 2018 | $420.16 | 5 | Alexion Pharmaceuticals, Inc. ($279.78) |
| 2017 | $309.23 | 6 | PFIZER INC. ($109.40) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2022 | Incyte Corporation | — | Education | Cash or cash equivalent | $85.95 | General |
| 09/24/2022 | Incyte Corporation | MONJUVI (Drug), JAKAFI, PEMAZYRE | Food and Beverage | Cash or cash equivalent | $24.13 | General |
| Category: Oncology | ||||||
| 09/21/2022 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $1,575.00 | General |
| 08/12/2022 | Incyte Corporation | JAKAFI (Drug), MONJUVI, PEMAZYRE | Food and Beverage | Cash or cash equivalent | $25.53 | General |
| Category: Hematology/Oncology | ||||||
| 08/04/2022 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $1,706.25 | General |
| 11/04/2020 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Oncology | ||||||
| 12/19/2018 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.95 | General |
| 12/07/2018 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $40.43 | General |
| Category: Hematology/Oncology | ||||||
| 05/31/2018 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $90.83 | General |
| 02/28/2018 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 02/28/2018 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Education | In-kind items and services | $89.95 | General |
| Category: Immunology | ||||||
| 08/21/2017 | PFIZER INC. | SUTENT (Drug) | Food and Beverage | In-kind items and services | $109.40 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
| 05/26/2017 | Incyte Corporation | — | Education | Cash or cash equivalent | $79.99 | General |
| 03/14/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.21 | General |
| Category: Oncology | ||||||
| 02/23/2017 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $93.35 | General |
| Category: Immunology | ||||||
| 02/23/2017 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Education | In-kind items and services | $2.14 | General |
| Category: Endocrinology | ||||||
| 02/23/2017 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Education | In-kind items and services | $2.14 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,213 | 54,473 | $747,964 | $135,245 |
| 2022 | 24 | 1,192 | 36,428 | $562,260 | $126,160 |
| 2021 | 26 | 1,366 | 50,619 | $724,273 | $151,503 |
| 2020 | 29 | 1,329 | 56,897 | $651,109 | $132,607 |
Total Patients
5,100
Total Services
198,417
Medicare Billing
$545,516
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 122 | 419 | $184,687 | $55,188 | 29.9% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 38 | 39,780 | $119,340 | $15,685 | 13.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 33 | 144 | $121,824 | $14,087 | 11.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 155 | $48,636 | $13,527 | 27.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 206 | 613 | $23,259 | $6,310 | 27.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 205 | 564 | $21,396 | $4,261 | 19.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 40 | 85 | $19,125 | $3,788 | 19.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 34 | 312 | $25,584 | $3,638 | 14.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $13,319 | $2,656 | 19.9% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 21 | 104 | $12,584 | $2,288 | 18.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $8,672 | $1,942 | 22.4% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 12 | 38 | $15,732 | $1,847 | 11.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 48 | 172 | $12,900 | $1,808 | 14.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 15 | 78 | $31,200 | $1,673 | 5.4% |
| 38221 | Biopsy of bone marrow | Office | 2023 | 13 | 13 | $9,646 | $1,588 | 16.5% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 34 | 46 | $8,694 | $1,206 | 13.9% |
| J1453 | Injection, fosaprepitant, 1 mg | Office | 2023 | 14 | 8,850 | $35,400 | $1,137 | 3.2% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 49 | 144 | $4,608 | $907.98 | 19.7% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 55 | 105 | $3,122 | $607.07 | 19.4% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2023 | 37 | 117 | $1,755 | $435.24 | 24.8% |
| 83735 | Magnesium level | Office | 2023 | 18 | 61 | $2,013 | $400.77 | 19.9% |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | Office | 2023 | 25 | 1,664 | $23,296 | $125.28 | 0.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 17 | 908 | $908.00 | $89.09 | 9.8% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 13 | 66 | $264.00 | $52.82 | 20.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 96 | 281 | $124,153 | $38,344 | 30.9% |
About Dr. Adarsh Hiremath, MD
Dr. Adarsh Hiremath, MD is a Hematology healthcare provider based in Gastonia, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2008. The National Provider Identifier (NPI) number assigned to this provider is 1578735478.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adarsh Hiremath, MD has received a total of $4,159 in payments from pharmaceutical and medical device companies, with $3,417 received in 2022. These payments were reported across 17 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($3,281).
As a Medicare-enrolled provider, Hiremath has provided services to 5,100 Medicare beneficiaries, totaling 198,417 services with total Medicare billing of $545,516. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Internal Medicine
- Location Gastonia, NC
- Active Since 03/31/2008
- Last Updated 07/15/2024
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1578735478
Products in Payments
- SOLIRIS (Drug) $284.44
- SUTENT (Drug) $109.40
- JAKAFI (Drug) $65.96
- MONJUVI (Drug) $24.13
- OPDIVO (Biological) $22.21
- DARZALEX (Biological) $12.51
- Strensiq (Drug) $2.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.